Literature DB >> 28656892

Clinical trials during epidemics.

Gerald T Keusch1, Keith P W J McAdam2.   

Abstract

Mesh：

Year:  2017        PMID： 28656892     DOI： 10.1016/S0140-6736(17)31602-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Evaluating Promising Investigational Medical Countermeasures: Recommendations in the Absence of Guidelines.

Authors:  Nahid Bhadelia; Lauren Sauer; Theodore J Cieslak; Richard T Davey; Susan McLellan; Timothy M Uyeki; Mark G Kortepeter
Journal:  Health Secur       Date:  2019-02-06

2.  Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review.

Authors:  Louise Sigfrid; Katherine Maskell; Peter G Bannister; Sharif A Ismail; Shelui Collinson; Sadie Regmi; Claire Blackmore; Eli Harriss; Kajsa-Stina Longuere; Nina Gobat; Peter Horby; Mike Clarke; Gail Carson
Journal:  BMC Med       Date:  2020-06-25       Impact factor: 8.775

3.  Ethics preparedness: facilitating ethics review during outbreaks - recommendations from an expert panel.

Authors:  Abha Saxena; Peter Horby; John Amuasi; Nic Aagaard; Johannes Köhler; Ehsan Shamsi Gooshki; Emmanuelle Denis; Andreas A Reis; Raffaella Ravinetto
Journal:  BMC Med Ethics       Date:  2019-05-06       Impact factor: 2.652

4.  Research Ethics Committees (RECs) and epidemic response in low and middle income countries.

Authors:  Luchuo Engelbert Bain; Chia Gerald Ngwain; Julius Nwobegahay; Jeffery Gabriel Sumboh; Rogers Nditanchou; Paschal Kum Awah
Journal:  Pan Afr Med J       Date:  2018-11-28

5.  Confronting the Multidimensional Challenges of Research in the Context of Emerging Infectious Diseases in Brazil: The Example of Yellow Fever.

Authors:  Vivian I Avelino-Silva; Claudia Figueiredo-Mello; Luciana V B Casadio; Ana C S S Nastri; Izabel Marcilio; Ana F Ribeiro; Anna S Levin; Ester C Sabino
Journal:  Am J Trop Med Hyg       Date:  2020-03-26       Impact factor: 2.345

Review 6.  A minimal common outcome measure set for COVID-19 clinical research.

Authors: 
Journal:  Lancet Infect Dis       Date:  2020-06-12       Impact factor: 25.071

7.  What treating Ebola means for pandemic influenza.

Authors:  David S Fedson
Journal:  J Public Health Policy       Date:  2018-08       Impact factor: 2.222
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.